Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer

CONCLUSION: Altogether, these data suggest that cytoplasmic LXR could be defined as a prognostic marker in early stage primary BC.PMID:34085098 | DOI:10.1007/s00432-021-03670-y

Source: Clinical Genitourinary Cancer - June 4, 2021 Category: Cancer & Oncology Authors: Wanting Shao Christina Kuhn Doris Mayr Nina Ditsch Magdalena Kailuwait Verena Wolf Nadia Harbeck Sven Mahner Udo Jeschke Vincent Cavaill ès Sophie Sixou Source Type: research